Cargando…

LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer

Prostate cancer (PCa) mortality is driven by highly aggressive tumors characterized by metastasis and resistance to therapy, and this aggressiveness is mediated by numerous factors, including activation of stress survival pathways in the pro-inflammatory tumor microenvironment. LEDGF/p75, also known...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basu, Anamika, Cajigas-Du Ross, Christina K., Rios-Colon, Leslimar, Mediavilla-Varela, Melanie, Daniels-Wells, Tracy R., Leoh, Lai Sum, Rojas, Heather, Banerjee, Hiya, Martinez, Shannalee R., Acevedo-Martinez, Stephanny, Casiano, Carlos A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714844/ https://www.ncbi.nlm.nih.gov/pubmed/26771192 http://dx.doi.org/10.1371/journal.pone.0146549

Ejemplares similares

Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes
por: Ríos-Colón, Leslimar, et al.
Publicado: (2017)

ERp57/GRP58: A protein with multiple functions
por: Turano, Carlo, et al.
Publicado: (2011)

Expression of the Stress Response Oncoprotein LEDGF/p75 in Human Cancer: A Study of 21 Tumor Types
por: Basu, Anamika, et al.
Publicado: (2012)

Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75
por: Mediavilla-Varela, Melanie, et al.
Publicado: (2009)

ERp57/PDIA3: new insight
por: Chichiarelli, Silvia, et al.
Publicado: (2022)

Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells
por: Sanchez-Hernandez, Evelyn S., et al.
Publicado: (2023)

The LEDGF/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant Prostate Cancer Cells
por: Ortiz-Hernandez, Greisha L., et al.
Publicado: (2021)

RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance
por: Cajigas-Du Ross, Christina K., et al.
Publicado: (2018)

Evidence for Recombinant GRP78, CALR, PDIA3 and GPI as Mediators of Genetic Instability in Human CD34+ Cells
por: Fabarius, Alice, et al.
Publicado: (2022)

Actin and Keratin are Binding Partners of the 1,25D(3)-MARRS Receptor/PDIA3/ERp57
por: LeBlanc, Tremaine, et al.
Publicado: (2014)

PDIA3/ERp57 promotes a matrix-rich secretome that stimulates fibroblast adhesion through CCN2
por: Hellewell, Andrew L., et al.
Publicado: (2022)

Twenty years of research on the DFS70/LEDGF autoantibody-autoantigen system: many lessons learned but still many questions
por: Ortiz-Hernandez, Greisha L., et al.
Publicado: (2020)

Multivalency of nucleosome recognition by LEDGF
por: Koutná, Eliška, et al.
Publicado: (2023)

A Comparative Analysis of Punicalagin Interaction with PDIA1 and PDIA3 by Biochemical and Computational Approaches
por: Paglia, Giuliano, et al.
Publicado: (2021)

The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding
por: Ochs, Robert L., et al.
Publicado: (2015)

Glucocorticoids Induce Stress Oncoproteins Associated with Therapy-Resistance in African American and European American Prostate Cancer Cells
por: Woods-Burnham, Leanne, et al.
Publicado: (2018)

Substrate Specificity of the Oxidoreductase ERp57 Is Determined Primarily by Its Interaction with Calnexin and Calreticulin
por: Jessop, Catherine E., et al.
Publicado: (2009)

Aromatic sulphonamides of aziridine-2-carboxylic acid derivatives as novel PDIA1 and PDIA3 inhibitors
por: Zelencova-Gopejenko, D., et al.
Publicado: (2023)

PDIA2 variant associated with vitiligo
por: Li, Fucheng, et al.
Publicado: (2023)

Potential implications of GRP58 expression and susceptibility of cervical cancer to cisplatin and thymoquinone-based therapy
por: Hafiza, Wan Abd Ghani Wan Nor, et al.
Publicado: (2014)

Diosgenin is an exogenous activator of 1,25D(3)-MARRS/Pdia3/ERp57 and improves Alzheimer's disease pathologies in 5XFAD mice
por: Tohda, Chihiro, et al.
Publicado: (2012)

Analysis of LEDGF/p75 expression regulation
por: Desfarges, Sébastien, et al.
Publicado: (2009)

The selenium-containing drug ebselen potently disrupts LEDGF/p75-HIV-1 integrase interaction by targeting LEDGF/p75
por: Zhang, Da-Wei, et al.
Publicado: (2020)

Depletion of the thiol oxidoreductase ERp57 in tumor cells inhibits proliferation and increases sensitivity to ionizing radiation and chemotherapeutics
por: Hussmann, Melanie, et al.
Publicado: (2015)

Impaired Bone Formation in Pdia3 Deficient Mice
por: Wang, Yun, et al.
Publicado: (2014)

The role of PDIA3 in myogenesis during muscle regeneration
por: Wang, Chao, et al.
Publicado: (2020)

Expression and Prognostic Significance of PDIA3 in Cervical Cancer
por: Zhang, Jing, et al.
Publicado: (2022)

Nitazoxanide inhibits paramyxovirus replication by targeting the Fusion protein folding: role of glycoprotein-specific thiol oxidoreductase ERp57
por: Piacentini, Sara, et al.
Publicado: (2018)

Protective Role for the Disulfide Isomerase PDIA3 in Methamphetamine Neurotoxicity
por: Pendyala, Gurudutt, et al.
Publicado: (2012)

Comparative Analysis of the Interaction between Different Flavonoids and PDIA3
por: Giamogante, Flavia, et al.
Publicado: (2016)

The Interaction Between Lentiviral Integrase and LEDGF: Structural and Functional Insights
por: Hare, Stephen, et al.
Publicado: (2009)

Structural basis for high-affinity binding of LEDGF PWWP to mononucleosomes
por: Eidahl, Jocelyn O., et al.
Publicado: (2013)

LEDGF/p75 Is Required for an Efficient DNA Damage Response
por: Liedtke, Victoria, et al.
Publicado: (2021)

Essential cell-extrinsic requirement for PDIA6 in lymphoid and myeloid development
por: Choi, Jin Huk, et al.
Publicado: (2020)

PDIA4 Correlates with Poor Prognosis and is a Potential Biomarker in Glioma
por: Li, Haoyu, et al.
Publicado: (2021)

PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas
por: Zhang, Hao, et al.
Publicado: (2021)

Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 in Multiple Myeloma
por: Hasipek, Metis, et al.
Publicado: (2021)

HIV-1 IN/Pol recruits LEDGF/p75 into viral particles
por: Desimmie, Belete Ayele, et al.
Publicado: (2015)

Differential expression of protein disulfide-isomerase A3 isoforms, PDIA3 and PDIA3N, in human prostate cancer cell lines representing different stages of prostate cancer
por: Diaz Cruz, Maria Araceli, et al.
Publicado: (2021)

Glucocorticoid Receptor and β-Catenin Interact in Prostate Cancer Cells and Their Co-Inhibition Attenuates Tumorsphere Formation, Stemness, and Docetaxel Resistance
por: Martinez, Shannalee R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_73s8qtooj9p9msdjbn343n7i6b